Rapid analysis of epitope-paratope interactions between HIV-1 and a 17- amino-acid neutralizing microantibody by electrospray ionization mass spectrometry

European Journal of Biochemistry

Volumn 258, Issue 1, 1998, Pages 164-169

  Millar, Alan L ^a   Jackson, Nicholas A C ^a   Dalton, Howard ^a   Jennings, Keith R ^a   Levi, Michael ^b   Wahren, Britta ^b   Dimmock, Nigel J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ESI MS; HIV 1; Mass spectrometry; Microantibody; Neutralization

Indexed keywords

AMINO ACID; EPITOPE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; NEUTRALIZING ANTIBODY;

AFRICA; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIVIRAL ACTIVITY; ARTICLE; BRAZIL; COMPLEMENTARITY DETERMINING REGION; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0032533971     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2580164.x     Document Type: Article

References (38)

1. Wilson, I. A. & Stanfield, R. L. (1994) Antibody-antigen interactions: new structures and new conformational changes, Curr. Opinion Struct. Biol. 4, 857-867.
2. Zvi, A., Feigelson, D. J., Hayek, Y. & Anglister, J. (1997) Conformation of the principal neutralizing determinant of human immunodeficiency virus type I in complex with an anti-gp 120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance spectroscopy, Biochem. 36, 8619-8627.
3. Zhao, Y. & Chait, B. T. (1994) Protein mapping by mass spectrometry, Anal. Chem. 66, 3723-3726.
4. Levi, M., Sällberg, M., Rud́en, U., Herlyn, D., Maruyama, H., Wigzell, H., Marks, J. & Wahren, B. (1993) A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro, Proc. Natl Acad. Sci. USA 90, 4374-4378.
5. UNAIDS Press Release (1997) New UN World AIDS Day report warns that HIV epidemic is far worse than previously thought.
6. Pantaleo, G. (1997) How immune-based interventions can change HIV therapy, Nature Med. 5, 483-486.
7. Burton, D. R. (1997) A vaccine for HIV type 1: the antibody perspective, Proc. Natl Acad. Sci. USA 94, 10018-10023.
8. D'Souza, M. P., Livnat, D., Bradac, J. A. & Bridges, S. H. (1997) Evaluation of monoclonal antibodies to human immunodeficiency virus type I primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials, J. Infect. Dis. 175, 1056-1062.
9. Dimmock, N. J., Mclnerney, T. L., Cordell, J., Barbas, C. F. III, Burton, D. R., Wahren, B., Hinkula, J., McLain, L. & Armstrong, S. J. (1996) Six HIV-1 gp120-specific monoclonal antibodies exhibit two mechanisms of neutralization: inhibition of attachment to the CD4 receptor is not one of them, in Vaccine 96 (Brown, F., Burton, D. R., Collier, J., Mekalonos, J. & Norrby, E., eds) pp. 143-148, Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory, NY.
10. Sattentau, Q. J. (1996) Neutralization of HIV-1 by antibody, Curr. Opinion Immunol. 8, 540-545.
11. Posner, M. R., Hideshima, T., Cannon, T., Mukherjee, M., Mayer, K. H. & Byrn, R. A. (1991) An IgG human monoclonal antibody that reacts with HIV-1/gpl20, inhibits virus binding to cells, and neutralizes infection, J. Immunol. 146, 4325-4332.
12. McInerney, T. L., McLain, L., Armstrong, S. J. & Dimmock, N. J. (1997) A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a post-fusion event, Virology 233, 313-326.
13. Ugolini, S., Mondor, I., Parren, P. W. H. I., Burton, D. R., Tilley, S. A., Klasse, P. J. & Sattentau, Q. J. (1997) Inhibition of virus attachment to CD4 target cells is a major mechanism of T cell line-adapted HIV-1 neutralization, J. Exp. Med. 186, 1287-1298.
14. Valenzuela, A., Blanco, J., Krust, B., Franco, R. & Hovanessian, A. G. (1997) Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells, J. Virol. 71, 8289-8298.
15. Armstrong, S. J., McInerney, T. L., McLain, L., Wahren, B., Hinkula, J., Levi, M. & Dimmock, N. J. (1996) Two neutralizing antiV3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1, J. Gen. Virol. 77, 2931-2941.
16. Dimmock, N. J. (1993) Neutralization of animal viruses, Curr. Topics Microbiol. Immunol. 183, 1-149.
17. Paterson, Y. (1992) Mapping antibody binding sites on protein antigens, Nature 356, 456-457.
18. Suckau, D., Kohl, J., Karwath, G., Schneider, K., Casaretto, M., Bitter-Suermann, D. & Przybylski, M. (1990) Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric mapping, Proc. Natl Acad. Sci. USA 87, 9848-9852.
19. Papac, D. I., Hoyes, J. & Tomer, K. B. (1994) Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption mass spectrometry, Protein Sci. 3, 1485-1492.
20. 111B p26 recognized by a monoclonal antibody, J. Immunol. 157, 198-206.
21. Jeyarajah, S., Parker, C. E., Sumner, M. T. & Tomer, K. B. (1998) Matrix-assisted laser desorption ionization mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody, J. Am. Soc. Mass Spectrom. 9, 157-165.
22. Macht, M., Fiedler, W., Kürzinger, K. & Przybylski, M. (1996) Mass spectrometric mapping of mycocardial infarct markers myoglobin and tropinin T, Biochem. 35, 15633-15639.
23. Lyubarskya, Y. V., Dunayevskiy, Y. M., Vouros, P. & Karger, B. L. (1997) Microscale epitope mapping by affinity capillary electrophoresis mass spectrometry, Anal. Chem. 69, 3008-3014.
24. Yu, L., Gaskell, S. J. & Brookman, J. L. (1998) Epitope mapping of monoclonal antibodies by mass spectrometry: identification of protein antigens in complex biological systems, J. Am. Soc. Mass Spectrom. 9, 208-215.
25. Winter, G. & Milstein, C. (1991) Man-made antibodies, Nature 349, 293-299.
26. Taub, R., Gould, R. J., Garsky, V. M., Ciccarone, T. M., Hoxie, J., Friedman, P. A. & Shattil, S. J. (1988) A monoclonal antibody against platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen, J Biol. Chem. 264, 259-265.
27. Welling, G. W., Geurts, T., van Gorkum, J., Damhof, R. A. & Drijfhout, W. (1991) A ten-residue fragment of an antibody (mini-antibody) directed against lysozyme as ligand in immunoaffinity chromatography, J. Chromatog. 548, 235-242.
28. Williams, W. V., Kieber-Emmons, T., VonFeldt, J., Greene, M. I. & Weiner, D. B. (1991) Design of bioactive peptides based on antibody hypervariable region structures, J. Biol. Chem. 266, 5182-5190.
29. Jarrin, A., Andrieux, A., Chapel, A., Buchou, T. & Marguerie, G. (1994) A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody, FEBS Lett. 354, 169-172.
30. Fontenot, J. D., Zacharopoulos, V. R. & Phillips, D. M. (1996) Proline-rich tandem repeats of antibody complementarity determining regions bind and neutralize human immunodeficiency type 1 particles. J Virol. 70, 6557-6562.
31. Bourgeois, C., Bour, J. B., Aho, L. S. & Pothier, P. (1998) Prophylactic administration of a complementarity-determining region from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice, J. Virol. 72, 807-810.
32. Åkerblom, L., Hinkula, J., Broliden, P-A., Mäkitalo, B., Fridberger, T., Rosen, J., Villacres-Erikssen, M., Morein, B. & Wahren, B. (1990) Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120, AIDS 4, 953-960.
33. McLain, L. & Dimmock, N. J. (1994) Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies, J. Gen. Virol. 75, 1457-1460.
34. Jackson, N. A. C., Levi, M., Wahren, B. & Dimmock, N. J. (1998) Mechanism of action of a 17 amino acid microantibody specific for the V3 loop that neutralizes free HIV-1 virions, J. Gen. Virol. 79, in the press.
35. Broliden, P. A., Mäkitalo, B., Åkerblom, L., Rosen, J., Broliden, K., Utter, G., Jondal, M., Norrby, E. & Wahren, B. (1991) Identification of amino acids in the V3 region of gp120 for virus neutralization by human HIV-1-specific antibodies, Immunol. 73, 371-376.
36. Broliden, P.-A., Ljunggren, K., Hinkula, J., Norrby, E., Åkerblom, L. & Wahren, B. (1990) A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization, J. Virol. 64, 936-940.
37. Rini, J. M., Stanfield, R. L., Stura, E. A., Salinas, P. A., Profy, A. T. & Wilson, I. A. (1993) Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide, Proc. Natl Acad. Sci. USA 90, 6325-6329.
38. Myers, G., Korber, B., Wain-Hobson, S., Smith, R. F. & Pavlakis, G. N., eds (1995) Human retroviruses and AIDS, 1995: a compilation and acid and amino acid sequences, Los Alamos National laboratory, Los Alamos, NM.